Last reviewed: June 15, 2026

Last updated: June 15, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide works by activating GLP-1 receptors in your brain and pancreas, signaling fullness and improving blood sugar control—effects that typically emerge within the first few weeks of treatment. The therapeutic dose for weight loss ranges from 0.25 mg to 2.4 mg weekly, with most patients finding their optimal balance somewhere in the middle range. Understanding how dosing works and what to expect can help you achieve lasting results without confusion or surprise costs.

How Semaglutide Dosing Works for Weight Loss

Semaglutide dosing follows a gradual escalation pattern designed to minimize side effects while building tolerance. Most patients start at a low dose—typically 0.25 mg per week—and increase every 4 weeks until reaching their therapeutic window. This slow titration allows your body to adapt to the medication's effects on appetite and metabolism, reducing nausea and other adjustment-period symptoms.

The therapeutic dose is not one-size-fits-all because individual factors shape how much semaglutide your body needs to produce weight loss results. Your age, baseline weight, metabolic rate, stomach sensitivity, and previous medication experiences all influence where your optimal dose lands. Clinical trials show that patients maintaining doses between 1.0 mg and 2.4 mg weekly experience the most consistent weight reduction and appetite suppression.

Why Individual Dose Requirements Vary Between Patients

Your genetic makeup influences how efficiently your GLP-1 receptors respond to semaglutide signaling. The GLP1R rs6923761 variant, one of 150+ genetic insights PlexusDx maps through its Precision Peptide Genetic Test, can affect how strongly your appetite-control pathways activate at a given dose. Patients with certain genetic predispositions may need lower doses to achieve the same weight loss response, while others benefit from reaching higher therapeutic ranges.

Beyond genetics, your lifestyle, dietary habits, and metabolic health shape dose requirements. Patients with insulin resistance or type 2 diabetes often see faster weight loss at moderate doses, while those with normal glucose metabolism may need gradual escalation to their therapeutic window. PlexusDx's approach recognizes these differences, offering personalized injectable semaglutide that adjusts to your unique response pattern rather than forcing you into a standard protocol.

What to Expect During Dose Escalation

The first two weeks at your starting dose introduce your body to semaglutide's mechanism—appetite reduction typically begins within 3–5 days, and most patients report noticeably smaller portions and reduced cravings by day 10. Common early experiences include mild nausea, slight fatigue, or changes in food preferences, which usually resolve as your body acclimates. These initial effects signal that the medication is working; they are not warnings to stop but normal adaptation signals.

As you increase your dose every 4 weeks, you may notice deeper appetite suppression and sustained energy improvements. Some patients experience a plateau in weight loss during dose escalation, which is normal—your body is recalibrating to the new medication level. The therapeutic dose for most patients produces steady 1–2 pound weekly weight loss once reached, with benefits continuing as long as the medication is taken consistently.

Compounded Semaglutide Injections: Affordability Without Dose Limitations

PlexusDx provides compounded semaglutide injections from licensed 503A compounding pharmacies, ensuring pharmaceutical-grade quality while eliminating the insurance barriers and high costs tied to brand medications. Pricing starts at just $149 per month across all commitment tiers, with a key distinction: your dose may increase toward your therapeutic range, but your price will not. This transparent model removes the financial penalty for finding your optimal dose.

Unlike insurance-dependent plans that tier prices by dose strength, PlexusDx charges one flat monthly rate whether you're at 0.25 mg or 2.4 mg. Semaglutide injections are HSA and FSA eligible, and PlexusDx serves all 50 states without requiring insurance approval or membership fees. After your first month on treatment, you can add the Precision Peptide Genetic Test for $99 to uncover genetic insights into your peptide-pathway response, helping your healthcare provider fine-tune your dose for maximum effectiveness.

Safety, Side Effects, and When to Adjust Your Dose

Semaglutide is well-tolerated at therapeutic doses when escalated gradually, with most side effects mild and temporary. Nausea, constipation, and reduced appetite are intended effects; they indicate the medication is engaging your GLP-1 system. However, if side effects become severe—persistent vomiting, severe stomach pain, or signs of dehydration—your dose may need to pause or decrease temporarily while you stabilize.

Your therapeutic dose is the one that produces consistent weight loss, improves your hunger signals, and fits within your daily life without overwhelming side effects. This balance point differs for every person; some reach it at 1.0 mg weekly, others at 2.4 mg. PlexusDx supports dose adjustments throughout your treatment by maintaining affordable, flat pricing so you can find your therapeutic window without financial barriers or insurance red tape.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is considered a therapeutic dose of semaglutide for weight loss?

The therapeutic dose of semaglutide for weight loss ranges from 0.5 mg to 2.4 mg weekly, with most patients finding optimal results between 1.0 mg and 2.4 mg. Your specific therapeutic dose depends on your metabolism, genetic factors, and how your body responds during gradual dose escalation. PlexusDx provides personalized compounded semaglutide injections at a flat $149/month price, regardless of which dose within your therapeutic range you ultimately need.

How long does it take to reach my therapeutic dose of semaglutide?

Most patients reach their therapeutic dose within 16–20 weeks, following a standard 4-week escalation schedule that starts at 0.25 mg and increases by 0.25 mg each month. Some patients find their optimal dose earlier, while others benefit from reaching higher doses for maximum weight loss. The gradual approach minimizes side effects and allows your healthcare provider to monitor your response safely.

Will I pay more if my semaglutide dose increases?

No. PlexusDx charges one flat monthly rate of $149 for compounded semaglutide injections across all tiers—your dose may go up to reach your therapeutic window, but your price will not. This transparent pricing removes the financial burden of dose escalation and ensures affordability as you find your optimal therapeutic range.

Can genetics affect my semaglutide therapeutic dose?

Yes. Genetic variants in your GLP1R and other peptide-pathway genes influence how strongly your body responds to semaglutide signaling, potentially shifting your therapeutic dose higher or lower. PlexusDx offers the Precision Peptide Genetic Test ($99 after your first treatment month) to map 150+ genetic insights across 49 peptides, helping your provider personalize your dose based on your genetic predispositions.

What if semaglutide side effects prevent me from reaching a higher dose?

If side effects are limiting your dose escalation, your healthcare provider may pause at your current dose level or adjust upward more slowly. Some patients find their therapeutic window at a lower dose than expected, and that is perfectly acceptable—your therapeutic dose is the one that works for your body. PlexusDx's flat pricing ensures you never face financial pressure to increase your dose beyond what feels safe and effective for you.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves